Welcome!

News Feed Item

Diarrhea Global Clinical Trials Review, H1, 2013

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diarrhea Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829678/Diarrhea-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Diarrhea Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Diarrhea Global Clinical Trials Review, H1, 2013" provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diarrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Diarrhea 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Diarrhea 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Diarrhea Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Optimer Pharmaceuticals, Inc. 35
Clinical Trial Overview of Optimer Pharmaceuticals, Inc. 35
Salix Pharmaceuticals, Inc. 36
Clinical Trial Overview of Salix Pharmaceuticals, Inc. 36
Romark Laboratories, L.C. 37
Clinical Trial Overview of Romark Laboratories, L.C. 37
Johnson & Johnson 38
Clinical Trial Overview of Johnson & Johnson 38
Intercell AG 39
Clinical Trial Overview of Intercell AG 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Ipsen S.A. 41
Clinical Trial Overview of Ipsen S.A. 41
Glenmark Pharmaceuticals Ltd. 42
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Mead Johnson Nutrition Company 44
Clinical Trial Overview of Mead Johnson Nutrition Company 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
AGI Therapeutics plc 46
Clinical Trial Overview of AGI Therapeutics plc 46
NIZO food research BV 47
Clinical Trial Overview of NIZO food research BV 47
Ventria Bioscience 48
Clinical Trial Overview of Ventria Bioscience 48
Bio-K+ International Inc. 49
Clinical Trial Overview of Bio-K+ International Inc. 49
Furiex Pharmaceuticals, Inc. 50
Clinical Trial Overview of Furiex Pharmaceuticals, Inc. 50
Friesland Coberco Dairy Foods Holding N.V. 51
Clinical Trial Overview of Friesland Coberco Dairy Foods Holding N.V. 51
Genzyme Corporation 52
Clinical Trial Overview of Genzyme Corporation 52
Nestle SA 53
Clinical Trial Overview of Nestle SA 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
ICDDR,B 54
Clinical Trial Overview of ICDDR,B 54
U.S. Centers for Disease Control and Prevention 55
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 55
International Vaccine Institute 56
Clinical Trial Overview of International Vaccine Institute 56
The University of Nottingham 57
Clinical Trial Overview of The University of Nottingham 57
The Johns Hopkins Bloomberg School of Public Health 58
Clinical Trial Overview of The Johns Hopkins Bloomberg School of Public Health 58
Aga Khan University 59
Clinical Trial Overview of Aga Khan University 59
Centro Pediatrico Albina de Patino 60
Clinical Trial Overview of Centro Pediatrico Albina de Patino 60
Johns Hopkins University 61
Clinical Trial Overview of Johns Hopkins University 61
University of Virginia 62
Clinical Trial Overview of University of Virginia 62
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Christian Medical College 64
Clinical Trial Overview of Christian Medical College 64
University of Pittsburgh 65
Clinical Trial Overview of University of Pittsburgh 65
Seoul National University Hospital 66
Clinical Trial Overview of Seoul National University Hospital 66
London School of Hygiene & Tropical Medicine 67
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 67
Shanghai University of Traditional Chinese Medicine 68
Clinical Trial Overview of Shanghai University of Traditional Chinese Medicine 68
Centre for International Health 69
Clinical Trial Overview of Centre for International Health 69
The University of Texas Health Science Center at Houston 70
Clinical Trial Overview of The University of Texas Health Science Center at Houston 70
John D. Dingell VA Medical Center 71
Clinical Trial Overview of John D. Dingell VA Medical Center 71
Medical University of Warsaw 72
Clinical Trial Overview of Medical University of Warsaw 72
Hadassah Medical Organization 73
Clinical Trial Overview of Hadassah Medical Organization 73
Five Key Clinical Profiles 74
Appendix 123
Abbreviations 123
Definitions 123
Research Methodology 124
Secondary Research 124
About GlobalData 125
Contact Us 125
Disclaimer 125
Source 126

List of Tables

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries, 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries, 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Diarrhea Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Diarrhea Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 34
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimer Pharmaceuticals, Inc., 2013* 35
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2013* 36
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2013* 37
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 38
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 39
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2013* 41
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Glenmark Pharmaceuticals Ltd., 2013* 42
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 43
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mead Johnson Nutrition Company, 2013* 44
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 45
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2013* 46
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2013* 47
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ventria Bioscience, 2013* 48
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc., 2013* 49
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Furiex Pharmaceuticals, Inc., 2013* 50
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Friesland Coberco Dairy Foods Holding N.V., 2013* 51
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 52
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2013* 53
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by ICDDR,B, 2013* 54
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 55
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by International Vaccine Institute, 2013* 56
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2013* 57
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins Bloomberg School of Public Health, 2013* 58
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2013* 59
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro Pediatrico Albina de Patino, 2013* 60
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 61
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 62
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 63
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2013* 64
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 65
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 66
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 67
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai University of Traditional Chinese Medicine, 2013* 68
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for International Health, 2013* 69
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 70
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2013* 71
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Warsaw, 2013* 72
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 73

List of Figures

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 124

To order this report:
Drug_Discovery_and_Development Industry:
Diarrhea Global Clinical Trials Review, H1, 2013

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Kubernetes, Docker and containers are changing the world, and how companies are deploying their software and running their infrastructure. With the shift in how applications are built and deployed, new challenges must be solved. In his session at @DevOpsSummit at19th Cloud Expo, Sebastian Scheele, co-founder of Loodse, will discuss the implications of containerized applications/infrastructures and their impact on the enterprise. In a real world example based on Kubernetes, he will show how to ...
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...
With so much going on in this space you could be forgiven for thinking you were always working with yesterday’s technologies. So much change, so quickly. What do you do if you have to build a solution from the ground up that is expected to live in the field for at least 5-10 years? This is the challenge we faced when we looked to refresh our existing 10-year-old custom hardware stack to measure the fullness of trash cans and compactors.
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions wi...
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Is the ongoing quest for agility in the data center forcing you to evaluate how to be a part of infrastructure automation efforts? As organizations evolve toward bimodal IT operations, they are embracing new service delivery models and leveraging virtualization to increase infrastructure agility. Therefore, the network must evolve in parallel to become equally agile. Read this essential piece of Gartner research for recommendations on achieving greater agility.